Evidence map›Paper›PMID 40281356›Full record

ArticleThe EMBO journal2025

Altering metabolism programs cell identity via NAD

Robert A Bone, Molly P Lowndes, Silvia Raineri, Alba R Riveiro, Sarah L Lundregan, Morten Dall, Karolina Sulek, Jose A H Romero, Luna Malzard, Sandra Koigi and 10 more

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Robert A BoneNovo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Molly P LowndesNovo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-3692-7847
Silvia RaineriNovo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-4381-1033
Alba R RiveiroNovo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-7015-2486
Sarah L LundreganNovo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Morten DallNovo Nordisk Foundation Center for Basic Metabolic Research, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-8577-3162
Karolina SulekNovo Nordisk Foundation Center for Basic Metabolic Research, Copenhagen, Denmark.
Jose A H RomeroNovo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-4765-2087
Luna MalzardNiels Bohr Institute, University of Copenhagen, Copenhagen, Denmark.
Sandra KoigiNovo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Indra J HeckenbachNiels Bohr Institute, University of Copenhagen, Copenhagen, Denmark.
Victor Solis-MezarinoMoleQlar Analytics GmbH, Rosenheimer Straße 141h, 81671, Munich, Germany.
Moritz Völker-AlbertMoleQlar Analytics GmbH, Rosenheimer Straße 141h, 81671, Munich, Germany.
Catherine G VasilopoulouDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Florian MeierDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID http://orcid.org/0000-0003-4729-175X
Ala TrusinaNiels Bohr Institute, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-1945-454X
Matthias MannNovo Nordisk Foundation Center for Protein Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-1292-4799
Michael L NielsenNovo Nordisk Foundation Center for Protein Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-0067-9039
Jonas T TreebakNovo Nordisk Foundation Center for Basic Metabolic Research, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-1488-7012
Joshua M BrickmanNovo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. joshua.brickman@sund.ku.dk.ORCID http://orcid.org/0000-0003-1580-7491

Funding

Danmarks Grundforskningsfond (DNRF) DNRF116European Union 101097979Lundbeck Foundation (Lundbeckfonden) DFF-0134-00022BLundbeck Foundation (Lundbeckfonden) DFF-2034-00025BLundbeck Foundation (Lundbeckfonden) DFF-8020-00100BLundbeck Foundation (Lundbeckfonden) R208-2015-2872Novo Nordisk Fonden (NNF) NNF21CC0073729Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research) NNF18CC0034900Novo Nordisk Foundation Center for Protein Research (CPR) NNF14CC0001Novo Nordisk Foundation Center for Protein Research (CPR) NNF24SA0098829
6 · The paper itself

Abstract

Cells change their metabolic profiles in response to underlying gene regulatory networks, but how can alterations in metabolism encode specific transcriptional instructions? Here, we show that forcing a metabolic change in embryonic stem cells (ESCs) promotes a developmental identity that better approximates the inner cell mass (ICM) of the early mammalian blastocyst in cultures. This shift in cellular identity depends on the inhibition of glycolysis and stimulation of oxidative phosphorylation (OXPHOS) triggered by the replacement of D-glucose by D-galactose in ESC media. Enhanced OXPHOS in turn activates NAD + -dependent deacetylases of the Sirtuin family, resulting in the deacetylation of histones and key transcription factors to focus enhancer activity while reducing transcriptional noise, which results in a robustly enhanced ESC phenotype. This exploitation of a NAD + /NADH coenzyme coupled to OXPHOS as a means of programming lineage-specific transcription suggests new paradigms for how cells respond to alterations in their environment, and implies cellular rejuvenation exploits enzymatic activities for simultaneous activation of a discrete enhancer set alongside silencing genome-wide transcriptional noise.

Indexed as

Embryonic Stem CellsNADAcetylationAnimalsCell DifferentiationGlucoseGlycolysisHistonesMiceOxidative PhosphorylationSirtuinsGlucoseHistonesNADSirtuinsAgingEnhancersMetabolismPluripotencySirtuins

Identifiers

PMID40281356
PMCPMC12130289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.